+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
From
Celiac Diseases Drugs - Global Strategic Business Report - Product Thumbnail Image

Celiac Diseases Drugs - Global Strategic Business Report

  • Report
  • May 2026
  • 367 Pages
  • Global
From
From
Desmoid Tumors Market - Global Strategic Business Report - Product Thumbnail Image

Desmoid Tumors Market - Global Strategic Business Report

  • Report
  • May 2026
  • 286 Pages
  • Global
From
Gastric Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer Market - Global Strategic Business Report

  • Report
  • May 2026
  • 582 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • May 2026
  • 246 Pages
  • Global
From
Pituitary Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Pituitary Cancer Market - Global Strategic Business Report

  • Report
  • May 2026
  • 575 Pages
  • Global
From
From
From
Autoinjectors - Global Strategic Business Report - Product Thumbnail Image

Autoinjectors - Global Strategic Business Report

  • Report
  • May 2026
  • 483 Pages
  • Global
From
From
US Axial Spondyloarthritis Market outlook to 2028 - Product Thumbnail Image

US Axial Spondyloarthritis Market outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
Wearable Injectors - Global Strategic Business Report - Product Thumbnail Image

Wearable Injectors - Global Strategic Business Report

  • Report
  • May 2026
  • 179 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Market Report 2026 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Monoclonal Antibodies - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibodies - Global Strategic Business Report

  • Report
  • May 2026
  • 462 Pages
  • Global
From
From
Cellular Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cellular Immunotherapy - Global Strategic Business Report

  • Report
  • May 2026
  • 386 Pages
  • Global
From
Loading Indicator